Pretransplant clinicopathological correlation in end-stage primary pulmonary hypertension

The aim of the study was to see if there was any correlation between the histopathology, ultrastructure, pulmonary endocrinology and clinical manifestations of end-stage primary pulmonary hypertension. Twenty patients undergoing heart-lung transplantation for the disease were studied. The nature and duration of symptoms and signs, results of haematological, electrocardiographic, radiographic, echocardiographic and haemodynamic studies, and the response of patients to vasodilators were compared with data from histopathological and ultrastructural study of lungs removed at transplantation. Length of clinical history and clinical evidence of severe disease were not necessarily associated with advanced histopathology, nor did the presence of small, contracted muscular pulmonary arteries imply responsiveness to vasodilators. Numbers of gastrin-releasing peptide-containing pulmonary endocrine cells were greater in lungs in which there was activity of myofibroblasts in pulmonary arterial vessels, and correlated negatively with mean pulmonary artery pressure and pulmonary artery systolic pressure. Whereas the prognosis of primary pulmonary hypertension cannot as yet be defined by other than its clinical manifestations, intimal proliferation as well as vasoconstriction may be important in its pathogenesis. The release of gastrin-releasing peptide from pulmonary endocrine cells may possibly be involved in this process.

This article has been cited by other articles:

				E. C. Dempsey, M. J. Wick, V. Karoor, E. J. Barr, D. W. Tallman, C. A. Wehling, S. J. Walchak, S. Laudi, M. Le, M. Oka, et al. Neprilysin Null Mice Develop Exaggerated Pulmonary Vascular Remodeling in Response to Chronic Hypoxia Am. J. Pathol., March 1, 2009; 174(3): 782 - 796. [Abstract] [Full Text] [PDF]

				D. J. Welsh, M. Harnett, M. MacLean, and A. J. Peacock Proliferation and Signaling in Fibroblasts: Role of 5-Hydroxytryptamine2A Receptor and Transporter Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 252 - 259. [Abstract] [Full Text] [PDF]

				P. Egermayer, G I. Town, and A. J Peacock Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension Thorax, February 1, 1999; 54(2): 161 - 168. [Full Text]